This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

CROMSOURCE Upgrades To The New Oracle Clinical Release 4.6.4

VERONA, Italy, January 29, 2013 /PRNewswire/ --

CROMSOURCE, a high quality ISO-certified international provider of outsourced services to the pharmaceutical, biotechnology and medical device industries, specialized in clinical development and staffing solutions, today announced successful completion of a project to upgrade their data management system to the new Oracle Clinical Release 4.6.4 (replacing version 4.5.3.).

'Over the past 15 years, the Biometrics group within CROMSOURCE has conducted hundreds of important projects either as part of full-service agreements or as stand-alone assignments across all segments of the healthcare research sector, including medical devices, pharmaceuticals, biotechnologies and vaccines,' noted Hugo Hartmans, Director of Biometrics. 'We consistently delight our clients by delivering high quality services and proactively searching for the most efficient solution. As part of this commitment to satisfy our clients' needs, evidenced by our 80% repeat business level, CROMSOURCE decided to invest in upgrading to the latest Oracle Clinical Release.'

Key benefits of the upgrade include availability of web-based randomisation, provision of email alerts on entry of certain defined data (e.g. SAEs), increased flexibility of eCRF design and flow, conditional navigation and other increases in general usability. The combined effect of these changes is to increase the ease, speed and accuracy of data handling which in turn creates cleaner data, faster.

The upgraded version of Oracle Clinical and Remote Data Capture (RDC) is now installed and hosted on the state-of-the-art infrastructure in the CROMSOURCE European Headquarters, and is fully validated and maintained in accordance with all applicable international guidelines.

'This is an important milestone and reflects our commitment to remaining at the forefront of technological innovation and providing best in class solutions to our clients,' stated Oriana Zerbini MD, Chief Executive Officer of CROMSOURCE. 'CROMSOURCE has an enviable record of delivering high quality statistics and data management projects to our sponsors on time, on budget and to the highest quality. I am convinced that this development will create many added benefits for our clients.'

About CROMSOURCE: CROMSOURCE is a high quality ISO-certified international provider of outsourced services to the pharmaceutical, biotechnology and medical device industries, specialized in clinical development and staffing solutions. The CROMSOURCE Biometrics team is headquartered in Aachen, Germany, with another large group working from the CROMSOURCE office in Stirling in the UK. During the last 15 years the Biometrics group at CROMSOURCE has completed over 230 data management projects and over 50 EDC based studies.

Contact: Margherita Mosconi CROMSOURCE Phone: +39-045-8222811 Fax: +39-045-8222812

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,156.85 +24.88 0.15%
S&P 500 2,001.57 +2.59 0.13%
NASDAQ 4,562.1890 +9.43 0.21%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs